Beyond Cancer reports early clinical activity in Phase 1 cancer trial
Beyond Cancer Ltd. reported early clinical activity and favorable safety results from its Phase 1 trial testing ultra-high concentration nitric ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
